Home › Funds › Octagon Capital Advisors LP › ABVX

Octagon Capital Advisors LP position in ABVX

ABIVAX SA · Health Care

Octagon Capital Advisors LP reported holding 993,000 shares of ABVX (ABIVAX SA) in its Q2 2026 13F filing — a position valued at US$132.3M, representing 11.89% of its reported portfolio and ranking #3 among its reported holdings. Octagon Capital Advisors LP has disclosed ABVX holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)993.00K sh
Reported value held$132.33M
Portfolio Weight11.89%
First reportedQ1 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Octagon Capital Advisors LP's ABVX position evolved

Octagon Capital Advisors LP first disclosed a stake in ABVX in Q1 2025 at 1,230,000 shares (US$7.7M). The position peaked in Q2 2026 at 993,000 shares, worth US$132.3M. Across 6 filings, Octagon Capital Advisors LP increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 993,000 shares valued at US$132.3M — an increase of 316,000 shares quarter over quarter.. Notable position changes include a 43% trim in Q4 2025 (shares fell 17% over the following quarter), a 47% increase in Q2 2026 (shares fell 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 1.23M $7.69M New
Q2 2025 1.27M $9.69M Add
Q3 2025 1.32M $112.49M Add
Q4 2025 756.00K $101.95M Reduce
Q1 2026 677.00K $75.38M Reduce
Q2 2026 993.00K $132.33M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABVX and 13F data

ABVX (ABIVAX SA) is a Health Care company. 72 other funds we track also report a position in ABVX — the largest reported positions include TCG Crossover Management, LLC (US$800.6M), Helikon Investments Ltd (US$371.4M), Darwin Global Management, Ltd. (US$348.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABVX

All ABVX fund holders →

FAQ

How long has Octagon Capital Advisors LP held ABVX?

Octagon Capital Advisors LP has disclosed ABVX holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Octagon Capital Advisors LP's current position in ABVX?

As of Q2 2026, Octagon Capital Advisors LP holds 993.00K shares of ABVX (ABIVAX SA), valued at $132.33M, representing 11.89% of its reported portfolio and ranking #3.

Has Octagon Capital Advisors LP been buying or selling ABVX?

In the latest 13F filing (Q2 2026), Octagon Capital Advisors LP increased its position in ABVX. The position peaked in Q2 2026 at 993.00K shares.

Which other funds hold ABVX?

Other major institutional holders of ABVX include TCG Crossover Management, LLC, Helikon Investments Ltd, Darwin Global Management, Ltd., among 72 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.